International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment-Reference-Cited by-同舟云学术

International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment

Published:2018-09 Issue:13 Volume:24 Page:3582-3592
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Blinova Ksenia,Dang Qianyu,Millard Daniel,Smith Godfrey,Pierson Jennifer,Guo Liang,Brock Mathew,Lu Hua Rong,Kraushaar Udo,Zeng Haoyu,Shi Hong,Zhang Xiaoyu,Sawada Kohei,Osada Tomoharu,Kanda Yasunari,Sekino Yuko,Pang Li,Feaster Tromondae K.,Kettenhofen Ralf,Stockbridge Norman,Strauss David G.,Gintant Gary

Funder

Food and Drug Administration Broad Agency Announcement

National Cancer Institute

NIH

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference29 articles.

1. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes;Ando;J. Pharmacol. Toxicol. Methods,2017

2. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes;Asakura;J. Pharmacol. Toxicol. Methods,2015